Cargando…
Evaluation of therapeutic effects of FAK inhibition in murine models of atherosclerosis
OBJECTIVE: Therapeutic effects of focal adhesion kinase (FAK) inhibition using a small molecule inhibitor was evaluated in apolipoprotein E (apoE) knockout (KO) and low-density lipoprotein receptor (LDLr) KO mouse atherosclerosis models. RESULTS: The prevention trial consisted of an 8-week treatment...
Autores principales: | Yamaura, Takeshi, Kasaoka, Tatsuhiko, Iijima, Naoko, Kimura, Masaaki, Hatakeyama, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446301/ https://www.ncbi.nlm.nih.gov/pubmed/30940182 http://dx.doi.org/10.1186/s13104-019-4220-5 |
Ejemplares similares
-
Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
por: Fukami, Shigemi, et al.
Publicado: (2019) -
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023) -
FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer
por: Kim, Young-Ho, et al.
Publicado: (2019) -
Experimental therapeutic assays of Tephrosia vogelii against Leishmania major infection in murine model: in vitro and in vivo
por: Marango, Sylvia Naliaka, et al.
Publicado: (2017) -
FAK in Cancer: From Mechanisms to Therapeutic Strategies
por: Chuang, Hsiang-Hao, et al.
Publicado: (2022)